G. Atalay Et Al. , "Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice?," Anti-cancer drugs , vol.14, pp.703-13, 2003
Atalay, G. Et Al. 2003. Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice?. Anti-cancer drugs , vol.14 , 703-13.
Atalay, G., Cardoso, F., Paesmans, M., Goldberg, R., & Bleiberg, H., (2003). Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice?. Anti-cancer drugs , vol.14, 703-13.
Atalay, Gül Et Al. "Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice?," Anti-cancer drugs , vol.14, 703-13, 2003
Atalay, Gül Et Al. "Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice?." Anti-cancer drugs , vol.14, pp.703-13, 2003
Atalay, G. Et Al. (2003) . "Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice?." Anti-cancer drugs , vol.14, pp.703-13.
@article{article, author={Gül BAŞARAN Et Al. }, title={Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice?}, journal={Anti-cancer drugs}, year=2003, pages={703-13} }